Wang, L., Wu, Y., Ren, Z., Chu, X., Chen, J., Liu, L., . . . Su, C. (2024, June). A retrospective study of first‐line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations. Cancer Medicine.
Chicagoスタイル(17版)引用形式Wang, Li, et al. "A Retrospective Study of First‐line Therapy and Subsequent Pyrotinib Treatment in Advanced Lung Adenocarcinoma with HER2 Mutations." Cancer Medicine Jun. 2024.
MLA(9版)引用形式Wang, Li, et al. "A Retrospective Study of First‐line Therapy and Subsequent Pyrotinib Treatment in Advanced Lung Adenocarcinoma with HER2 Mutations." Cancer Medicine, Jun. 2024.
警告: この引用は必ずしも正確ではありません.